<DOC>
	<DOCNO>NCT01893437</DOCNO>
	<brief_summary>This single-center , randomize , double-blind , placebo-controlled , single dose study investigate safety , pharmacokinetics , pharmacodynamics RO6799477 healthy volunteer .</brief_summary>
	<brief_title>A Study RO6799477 Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>Male healthy volunteer , age 1845 year , inclusive Male volunteer female partner childbearing potential must agree use effective form birth control study 3 month discontinuation treatment . Body Mass index ( BMI ) 1830 kg/m2 , inclusive Infection human immunodeficiency virus antibody ( HIV 1 2 ) , Hepatitis B , hepatitis C Positive test drug abuse Any history alcohol and/or drug abuse addiction</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>